SB334867 attenuates the somatic expression of naloxone-precipitated morphine withdrawal.
- M. Luisa Laorden (117089)
- Szilamér Ferenczi (305600)
- Bernadett Pintér-Kübler (323635)
- Laura L. González-Martín (323637)
- M. Carmen Lasheras (323639)
- Krisztina J. Kovács (305598)
- M. Victoria Milanés (117091)
- Cristina Núñez (117092)
Publication date
February 2013
DOIAbstract
<p>Two-way ANOVA with chronic treatment (morphine vs. placebo) and pretreatment before naloxone (SB334867 vs. vehicle) as between-subjects factors. When significant interactions in pretreatment or between these two factors were observed, a subsequent <i>post hoc</i> test was applied.</p
Add to ORKG